Atea Pharmaceuticals Inc. (AVIR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Jean-Pierre Sommadossi
Employees:
9
125 SUMMER STREET, 16TH FLOOR, BOSTON, MA 02110
857-204-8109

We are a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections.

View recent insider trading info

Funds Holding AVIR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVIR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

12 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MURPHY POLLY A.

  • Director
23,295 2021-12-20 1

BERGER FRANKLIN M

  • Director
820,019 2020-11-03 0

ROCK SPRINGS CAPITAL MANAGEMENT LP

ROCK SPRINGS CAPITAL MASTER FUND LP

ROCK SPRINGS CAPITAL LLC

  • 10% Owner
No longer subject to file 2020-11-03 0

HACK ANDREW A. F.

  • Director
5,615,659 2020-11-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MURPHY POLLY A. - Director

2021-12-21 21:41:07 -0500 2021-12-20 P 12,000 $8.57 a 23,295 direct -0.2191 -0.8762 3.2859 3 -3.3954 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 22:15:04 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 21:45:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 21:15:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 20:45:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 20:15:04 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 19:45:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 19:15:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 18:45:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 18:15:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 17:45:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 17:15:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 16:45:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 16:15:04 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 15:45:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 15:15:03 UTC -0.1979 0.2679 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 14:45:03 UTC -0.1892 0.2592 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 14:15:03 UTC -0.1892 0.2592 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 13:45:03 UTC -0.1892 0.2592 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 13:15:03 UTC -0.1892 0.2592 950000
ATEA PHARMACEUTICALS INC AVIR 2022-01-17 12:45:03 UTC -0.1892 0.2592 950000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AVIR -13000.0 shares, $-455780.0 2021-09-30 N-PORT

Elevate your investments